SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-17-015657
Filing Date
2017-03-10
Accepted
2017-03-10 08:17:24
Documents
5
Effectiveness Date
2017-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 a17-8038_1s8.htm S-8 145266
2 EX-5.1 a17-8038_1ex5d1.htm EX-5.1 22618
3 EX-23.1 a17-8038_1ex23d1.htm EX-23.1 2022
4 GRAPHIC g80381kii001.jpg GRAPHIC 2334
5 GRAPHIC g80381kii002.jpg GRAPHIC 2041
  Complete submission text file 0001104659-17-015657.txt   177236
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216590 | Film No.: 17680256
SIC: 2834 Pharmaceutical Preparations